Abstract | OBJECTIVE: DESIGN: Retrospective review. SETTING: Hospital. PATIENTS: MAIN OUTCOME MEASURES: Preoperative sestamibi scans were reviewed, and their influence on the surgical outcome was examined. Records of the intraoperative and postoperative findings were also reviewed. RESULTS: Seventy-seven patients (17.0%) were found to have negative results on preoperative sestamibi scans, and these patients formed our cohort study group. In this group, neck ultrasonography performed as an adjunct was able to preoperatively localize an area that was suggestive of a single adenoma in 61 patients (79.2%), 53 of whom were confirmed to have a single adenoma intraoperatively (sensitivity, 80.3%; specificity, 27.3%; positive predictive value, 86.9%; and negative predictive value, 18.8%). In total, 66 of 77 patients (85.7%) were confirmed to have a single adenoma at the time of surgery. CONCLUSIONS: Negative results on sestamibi scans should not be used as exclusion criteria for minimally invasive/focused parathyroidectomy in patients with primary hyperparathyroidism. In our study, 66 patients with negative results on preoperative scans were found to have a single adenoma and were surgically cured by minimally invasive/focused parathyroidectomy.
|
Authors | Emad Kandil, Ahmed Jan Malazai, Saud Alrasheedi, Ralph P Tufano |
Journal | Archives of otolaryngology--head & neck surgery
(Arch Otolaryngol Head Neck Surg)
Vol. 138
Issue 3
Pg. 223-5
(Mar 2012)
ISSN: 1538-361X [Electronic] United States |
PMID | 22351855
(Publication Type: Journal Article)
|
Chemical References |
- Radiopharmaceuticals
- Technetium Tc 99m Sestamibi
|
Topics |
- Female
- Humans
- Hyperparathyroidism, Primary
(diagnostic imaging, surgery)
- Male
- Middle Aged
- Minimally Invasive Surgical Procedures
- Parathyroidectomy
(methods)
- Predictive Value of Tests
- Radiopharmaceuticals
- Retrospective Studies
- Sensitivity and Specificity
- Technetium Tc 99m Sestamibi
- Tomography, Emission-Computed, Single-Photon
- Treatment Outcome
- Ultrasonography
|